We have developed a novel, patent-pending, fluid reactor system that is targeted for (1) imporoved Extracorporeal Membrane Oxygenation (ECMO) devices utilized in heart- lung machines by enabling i) their use for an extended duration ii) manufacture of ECMO devices that operate on air instead of pure oxygen for special logistically challenged situations, iii) reduce the amount of donor blood needed for an operation and and iv) reduce the pressure needed for operation and (2) provide enhancements for other fluid reaction based applications such as dialysis, chemical, pharma and biomaterial manufacturing; filtration; fluid gasification and degasification; desalination; etc. These fluid reactor devices are enabled by a family of novel Reactor Core Elements (RCE) made from a free-standing, self- supporting, carbon-infiltrated c-VACNTTM material.
Journal: TechConnect Briefs
Volume: TechConnect Briefs 2019
Published: June 17, 2019
Pages: 103 - 106
Industry sector: Advanced Materials & Manufacturing
Topics: 3D Printing, Advanced Manufacturing